Iverpraz Syringe Oral Paste

Description

Iverpraz Syringe Oral Paste

Ivermectin 18.7 mg

Praziquantel 140.3 mg

Uses:

For the treatment of mixed cestode and nematode or arthropod infestations, due to adult and immature roundworms, lungworms, bots and tapeworms in horses:

Nematodes: Large strongyle: Strongylus vulgaris (adult and arterial larvae), Strongylus edentatus (adult and L4 tissue larval stages), Strongylus equinus (adult), Tridontophorus spp. (adult) Small strongyle: Cyathostomum: Cylicocyclus spp., Cylicostephanus spp.,Cylicodontophorus spp., Gyalocephalus spp. (adult and non-inhibited mucosal larvae) Parascaris: Parascaris equorum (adult and larvae) Oxyuris: Oxyuris equi (larvae)Trichostrongylus: Trichostrongylus axei (adult)

Strongyloides: Strongyloides westeri (adult) Habronema: Habronema spp. (adult) Onchocerca: Onchocerca spp. microfilariae i.e. cutaneous onchocerciasis

Lungworm: Dictyocaulus arnfieldi (adult and larvae) Cestodes (Tapeworm): Anoplocephala perfoliata, Anoplocephala magna, Paranoplocephala mamillana (adult)

Dipteran insects: Gasterophilus spp. (larvae) As tapeworm infestation is unlikely to occur in horses before two months of age, treatment of foals below this age is not considered necessary.

Dosage & Administration

Single administration

200 µg of Ivermectin and 1.5 mg of Praziquantel per kg of bodyweight corresponding to 1.07 g of paste per 100 kg bodyweight

Withdrawal Period:

Horses: Meat & Offal: 35 days

Not permitted for use in horses producing milk for human consumption.

Contraindictions, Warnings etc:

Do not use in foals under 2 weeks of age.

Do not use in mares from which milk is taken for human consumption.

Do not use in horses known to be hypersensitive to active ingredients or to any other ingredients.

Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: